Clinical presentation of meningococcal disease in childhood

Journal of Preventive Medicine and Hygiene

Volumn 53, Issue 2, 2012, Pages 116-119

  Sabatini, C ^a   Bosis, S ^a   Semino, M ^a   Senatore, L ^a   Principi, N ^a   Esposito, S ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Meningitis; Meningococcal disease; Neisseria meningitidis

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; MENINGOCOCCUS VACCINE; PENICILLIN G; RIFAMPICIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BEHAVIOR DISORDER; BLOODSTREAM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CULTURE; CHILDHOOD DISEASE; COGNITIVE DEFECT; DISEASE SEVERITY; HUMAN; HYDROCEPHALUS; LEG PAIN; MENINGOCOCCEMIA; MENINGOCOCCOSIS; MORTALITY; MOTOR DYSFUNCTION; NASOPHARYNX; NEISSERIA MENINGITIDIS; NONHUMAN; OUTCOME ASSESSMENT; PEDIATRICIAN; PERCEPTION DEAFNESS; PETECHIA; POLYMERASE CHAIN REACTION; RASH; SEIZURE; SURVIVOR;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES;

EID: 84864677440     PISSN: 11212233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006;367:397-403. (Pubitemid 43184259)
2. Rajapaksa S, Starr M. Meningococcal sepsis. Aust Fam Physician 2010;39:276-8.
3. Tan LK, Carlone GM, Borrow R. Advances in the development of vaccines against Neisseria meningitidis. N Engl J Med 2010;362:1511-20.
4. Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease. N Engl J Med 2001;344:1378-88.
5. Jódar L, Feavers IM, Salisbury D, et al. Development of vaccines against meningococcal disease. Lancet 2002;359:1499-508. (Pubitemid 34457772)
6. O'Toole L, Muscatello DJ, Zheng W, et al. Can near real-time monitoring of emergency department diagnoses facilitate early response to sporadic meningococcal infection? Prospective and retrospective evaluations. BMC Infect Dis 2010;10:309.
7. Brent AJ, Lakhanpaul M, Thompson M, et al. Risk score to stratify children with suspected serious bacterial infection: observational cohort study. Arch Dis Child 2011;96:361-7.
8. Hazelzet JA. Diagnosing meningococcemia as a cause of sepsis. Pediatr Crit Care Med 2005;6(3 Suppl.):S50-S54. (Pubitemid 40724253)
9. Wells LC, Smith JC, Weston VC, et al. The child with a nonblanching rash: How likely is meningococcal disease? Arch Dis Child 2001;85:218-22. (Pubitemid 32822382)
10. Nielsen HE, Andersen EA, Andersen J, et al. Diagnostic assessment of haemorrhagic rash and fever. Arch Dis Child 2001;85:160-5. (Pubitemid 32701687)
11. Wendlandt D, King B, Ziebell C, et al. Atypical presentation of fatal meningococcemia: peritonitis and paradoxical centrifugal purpura fulminans of late onset. Am J Emerg Med 2011;29:960.e3-e5.
12. Vasilopoulou VA, Karanika M, Theodoridou K, et al. Prognostic factors related to sequelae in childhood bacterial meningitis: data from a Greek meningitis registry. BMC Infect Dis 2011;11:214.
13. Visintin C, Mugglestone MA, Fields EJ, et al. Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance. BMJ 2010;340:c3209.
14. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-84. (Pubitemid 39458512)
15. Gardner P. Clinical practice. Prevention of meningococcal disease. N Engl J Med 2006;355:1466-73. (Pubitemid 44511561)
16. Gossger N, Snape MD, Yu LM, et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA 2012;307:573-82.